Impact of tricuspid regurgitation in aortic valve surgery
This retrospective study investigated the prognostic implications of tricuspid regurgitation (TR) in a cohort of 2679 patients who underwent surgical aortic valve replacement (AVR), specifically assessing the potential benefit of concomitant tricuspid valve intervention in those with moderate TR.
Significant mitral regurgitation and mortality: is moderate mitral regurgitation less benign than we think?
This observational study explores the association between mitral regurgitation (MR) severity and both cardiovascular and all-cause mortality.
Impella CP in post-infarction cardiogenic shock: does age matter?
This substudy of the DanGer Shock trial assessed outcomes associated with the use of Impella CP® for the management of cardiogenic shock (CS) secondary to myocardial infarction (MI) according to patient age.
Does permanent pacemaker implantation influence long-term survival after cardiac surgery?
This meta-analysis of 28 studies sought to evaluate the prognostic impact of permanent pacemaker (PPM) implantation in the postoperative period of cardiac surgery, with a focus on surgical procedure type and device indication.
Clinical surveillance or valve replacement in asymptomatic severe aortic stenosis: the eternal question
A meta-analysis of four randomized controlled trials (RCTs) comparing early aortic valve replacement (either surgical or transcatheter) with a conservative strategy of close clinical surveillance in patients with asymptomatic severe aortic stenosis.
How to address perioperative bleeding in cardiac surgery
Consensus document on bleeding management, transfusion, and quality metrics in cardiac surgery
The limitations of an unidimensional assessment of aortic aneurysms
Substudy of the prospective, multicenter, randomized TITAN:SvS trial evaluating candidates for ascending aortic surgery using alternative metrics beyond aortic diameter.
Acute type A intramural hematoma: is it truly less deadly
This is a retrospective observational study from a high-volume center addressing aortic intramural hematoma (IMH) as a distinct clinical entity within the acute aortic syndrome (AAS) spectrum. The authors outline their therapeutic approach, with particular emphasis on surgical strategy and patient selection based on the hematoma’s location and radiological progression.
